We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck and GlaxoSmithKline called for more information from the FDA in comments on the agency’s draft guidance for sponsors using the limited population pathway for antibacterial and antifungal drugs (LPAD). Read More
Purdue Pharma violated a 2015 agreement with New York by deceptively marketing opioids, including Oxycontin, New York Attorney General Barbara Underwood alleges in a new lawsuit. Read More
Ohio will require pharmacy benefit managers (PBM) contracting with its Medicaid program to end their current “spread pricing” arrangements and shift to a more transparent pricing model on Jan. 1. Read More
The U.S. Court of Appeals said AHF could not demonstrate any connection to the intellectual property that gave it standing for a patent case. Read More
The AIDS Healthcare Foundation petitioned the U.S. Supreme Court to review a lawsuit that challenges the validity of Gilead’s patents on its widely-used HIV/AIDS drug Tenofovir Alafenamide (TAF). Read More
Australia’s Therapeutic Goods Administration issued draft guidance for sponsors on prescription drug boxed warnings recommending the use of formats designed to instantly grab readers’ attention. Read More